Search

Author/Creator Perisa, Vlatka

1. C reactive protein to albumin ratio as prognostic marker in primary and secondary myelofibrosis. Issue 12 (14th October 2020)

Authors:
Lucijanic, Marko; Galusic, Davor; Krecak, Ivan; Sedinic, Martina; Soric, Ena; Holik, Hrvoje; Perisa, Vlatka; Moric Peric, Martina; Zekanovic, Ivan; Stoos-Veic, Tajana; Kusec, Rajko
Journal:
Leukemia & lymphoma
Issue:
Volume 61:Issue 12(2020)
Page Start:
2969
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Dose‐adjusted EPOCH and rituximab (DA‐EPOCH‐R) in older patients with high‐risk aggressive diffuse large B‐cell lymphoma: A real‐life multicenter study by the Croatian Cooperative Group for Hematologic diseases (KroHem). (2nd April 2023)

Authors:
Mitrovic, Zdravko; Dujmovic, Dino; Jaksic, Ozren; Kinda, Sandra Basic; Gacina, Petar; Perisa, Vlatka; Prka, Zeljko; Dreta, Barbara; Galusic, Davor; Holik, Hrvoje; Pejsa, Vlatko; Aurer, Igor
Journal:
European journal of haematology
Issue:
Volume 110:Number 6(2023)
Page Start:
725
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Patients with post polycythemia vera myelofibrosis might experience increased thrombotic risk in comparison to primary and post essential thrombocythemia myelofibrosis. (August 2022)

Authors:
Lucijanic, Marko; Krecak, Ivan; Soric, Ena; Sabljic, Anica; Galusic, Davor; Holik, Hrvoje; Perisa, Vlatka; Moric Peric, Martina; Zekanovic, Ivan; Kusec, Rajko
Journal:
Leukemia research
Issue:
Volume 119(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗